Gizem Kaleli‐Can

Hydroxyapatite-Based Targeted Drug Delivery Systems for HER2-Positive Breast Cancer: The Role of Trastuzumab and Folic Acid Functionalization

Worldwide, breast cancer continues to be one of the most frequently diagnosed malignancies and continues to pose a significant challenge in cancer therapy. Despite the significant improvement in patient survival that HER2-targeted therapies, such as trastuzumab, have achieved, th...

Hydroxyapatite-Based Targeted Drug Delivery Systems for HER2-Positive Breast Cancer: The Role of Trastuzumab and Folic Acid Functionalization

Worldwide, breast cancer continues to be one of the most frequently diagnosed malignancies and continues to pose a significant challenge in cancer therapy. Despite the significant improvement in patient survival that HER2-targeted therapies, such as trastuzumab, have achieved, th...